These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31990337)

  • 21. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Maksimowicz-McKinnon K; Selzer F; Manzi S; Kip KE; Mulukutla SR; Marroquin OC; Smitherman TC; Kuller LH; Williams DO; Wasko MC
    Circ Cardiovasc Interv; 2008 Dec; 1(3):201-8. PubMed ID: 20031679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.
    Lai CH; Hsieh CY; Barnado A; Huang LC; Chen SC; Tsai LM; Shyr Y; Li CY
    Rheumatology (Oxford); 2020 Jun; 59(6):1355-1363. PubMed ID: 31600392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients.
    Katz G; Smilowitz NR; Blazer A; Clancy R; Buyon JP; Berger JS
    Mayo Clin Proc; 2019 Aug; 94(8):1436-1443. PubMed ID: 31303426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.
    Valle JA; Tamez H; Abbott JD; Moussa ID; Messenger JC; Waldo SW; Kennedy KF; Masoudi FA; Yeh RW
    JAMA Cardiol; 2019 Feb; 4(2):100-109. PubMed ID: 30601910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention.
    Istanbuly S; Matetic A; Mohamed MO; Panaich S; Velagapudi P; Elgendy IY; Paul TK; Alkhouli M; Mamas MA
    Am J Cardiol; 2021 Oct; 156():32-38. PubMed ID: 34348842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Myocardial Infarction Outcomes in Systemic Lupus Erythematosus (from the Nationwide Inpatient Sample).
    Ando T; Adegbala O; Akintoye E; Ashraf S; Briasoulis A; Takagi H; Afonso L
    Am J Cardiol; 2019 Jan; 123(2):227-232. PubMed ID: 30424870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of coronary artery bypass grafting in patients with inflammatory rheumatic diseases: an 11-year nationwide cohort study.
    Lai CH; Lai WW; Chiou MJ; Tsai LM; Wen JS; Li CY
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):859-66.e1-2. PubMed ID: 25541410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignancy in systemic lupus erythematosus.
    Abu-Shakra M; Gladman DD; Urowitz MB
    Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.
    Faridi KF; Rymer JA; Rao SV; Dai D; Wojdyla D; Yeh RW; Wang TY
    Am Heart J; 2019 Oct; 216():53-61. PubMed ID: 31401443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis.
    Chakravarty EF; Nelson L; Krishnan E
    Arthritis Rheum; 2006 Mar; 54(3):899-907. PubMed ID: 16508972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
    Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal Trends and Outcomes of Percutaneous Coronary Interventions in Nonagenarians: A National Perspective.
    Goel K; Gupta T; Gulati R; Bell MR; Kolte D; Khera S; Bhatt DL; Rihal CS; Holmes DR
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1872-1882. PubMed ID: 30236360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.
    Rashid M; Rushton CA; Kwok CS; Kinnaird T; Kontopantelis E; Olier I; Ludman P; De Belder MA; Nolan J; Mamas MA
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2258-2265. PubMed ID: 29169494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis.
    Kao AH; Wasko MC; Krishnaswami S; Wagner J; Edmundowicz D; Shaw P; Cunningham AL; Danchenko N; Sutton-Tyrrell K; Tracy RP; Kuller LH; Manzi S
    Am J Cardiol; 2008 Sep; 102(6):755-60. PubMed ID: 18774002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention.
    Ayoub K; Marji M; Ogunbayo G; Masri A; Abdel-Latif A; Ziada K; Vallurupalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1862-1868. PubMed ID: 30172792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.
    Ram Poudel D; George M; Dhital R; Karmacharya P; Sandorfi N; Derk CT
    Rheumatology (Oxford); 2018 Sep; 57(9):1611-1622. PubMed ID: 29868788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Harris N; Eudy A; Clowse M
    Arthritis Care Res (Hoboken); 2019 Mar; 71(3):390-397. PubMed ID: 29908013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.
    Restivo V; Candiloro S; Daidone M; Norrito R; Cataldi M; Minutolo G; Caracci F; Fasano S; Ciccia F; Casuccio A; Tuttolomondo A
    Autoimmun Rev; 2022 Jan; 21(1):102925. PubMed ID: 34454117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
    Marchioni Beery RM; Barnes EL; Nadkarni A; Korzenik JR
    Inflamm Bowel Dis; 2017 Dec; 24(1):25-34. PubMed ID: 29272476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.